Clinical Trials Logo

Clinical Trial Summary

Patients with Crohns' disease (CD) are always complicated with malnutrition. Exclusive enteral nutrition (EEN) is an effective treatment to improve nutritional status and induce remission in patients with CD however a reduction in microbiota diversity was the most frequently reported effect of EEN. There was a raised critical question that whether EEN combining microbiota transplantation can bring much more benefits to those CD patients with malnutrition.

Fecal microbiota transplantation (FMT) is an effective way of remodeling microbiota. The improved methodology of FMT in our group since 2014 was different from the traditional manual FMT and was recently coined as washed microbiota transplantation (WMT), which is dependent on the automatic facilities and washing process in a laboratory room with biosafety level 3.

Importantly, the worse nutritional status might decrease the efficacy of FMT. Therefore, there was a raised critical question that when is the proper time to combine WMT for those CD patients requiring EEN. This trial aimed to explore the timing of WMT in CD patients with malnutrition and assess the efficacy and safety of the strategy using WMT combined with EEN in CD patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02897661
Study type Interventional
Source The Second Hospital of Nanjing Medical University
Contact Faming Zhang, MD; PHD
Phone 15005160838
Email fzhang@njmu.edu.cn
Status Recruiting
Phase N/A
Start date August 2016
Completion date December 2020

See also
  Status Clinical Trial Phase
Recruiting NCT01793831 - Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases N/A
Recruiting NCT02675153 - To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture N/A